4//SEC Filing
Daruwala Paul 4
Accession 0001610618-21-000021
CIK 0001610618other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 9:03 PM ET
Size
5.4 KB
Accession
0001610618-21-000021
Insider Transaction Report
Form 4
Daruwala Paul
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-03-17+120,000→ 120,000 totalExercise: $2.55Exp: 2031-03-16→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001639144
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 9:03 PM ET
- Size
- 5.4 KB